Symbiotec Pharmalab IPO listing today: Will it list at a premium or discount? Here's what the latest GMP signals

How 1 sources are covering this

• MintLean R·1h ago

  Symbiotec Pharmalab IPO listing today: Will it list at a premium or discount? Here's what the latest GMP signals

  Symbiotec Pharmalab prepares for its IPO listing today.  Analysts predict a potential 20-22% rise based on the latest grey market premium. 

  Read at Mint →